共 50 条
A Review of Coronavirus Disease 2019 in Pregnancy
被引:0
|作者:
Zamparini, Jarrod
[1
,2
,7
]
Saggers, Robin
[3
,4
]
Buga, Chandia Edward
[5
,6
]
机构:
[1] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Johannesburg, South Africa
[2] Charlotte Maxeke Johannesburg Acad Hosp, Dept Internal Med, Johannesburg, South Africa
[3] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa
[4] Charlotte Maxeke Johannesburg Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa
[5] Univ Witwatersrand, Fac Hlth Sci, Dept Obstet & Gynaecol, Johannesburg, South Africa
[6] Thelle Mogoerane Reg Hosp, Dept Obstet & Gynaecol, Vosloorus, South Africa
[7] Charlotte Maxeke Johannesburg Acad Hosp, Dept Internal Med, Area 552, ZA-2193 Johannesburg, South Africa
关键词:
pregnancy;
COVID-19;
maternal mortality;
vaccination;
RNA COVID-19 VACCINE;
SARS-COV-2;
INFECTION;
OUTCOMES;
SUSCEPTIBILITY;
INFLUENZA;
IMPACT;
WOMEN;
D O I:
10.1055/s-0042-1758853
中图分类号:
R4 [临床医学];
学科分类号:
1002 ;
100602 ;
摘要:
Pregnancy is an independent risk factor for morbidity and mortality in coronavirus disease 2019 (COVID-19) with increased rates of operative delivery, intensive care unit admission, and mechanical ventilation as well as a possible increased risk of death, independent of other risk factors, compared with nonpregnant women with COVID-19. Furthermore, pregnancy outcomes are worse in those with COVID-19 with increased risk for preeclampsia, venous thromboembolism, preterm birth, miscarriage, and stillbirth compared with pregnant women without COVID-19. Importantly, pregnant women of nonwhite ethnicity appear to be at greater risk of severe COVID-19, necessitating improved access to care and closer monitoring in these women. The management of COVID-19 in pregnancy is largely similar to that in nonpregnant people; however, there is an important emphasis on multidisciplinary team involvement to ensure favorable outcomes in both mother and baby. Similarly, vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is safe in pregnancy and improves maternal and neonatal outcomes.
引用
收藏
页码:50 / 65
页数:16
相关论文